logo
Providers Made Large Profits from Asylum Hotels but Haven't Returned Excess, MPs Told

Providers Made Large Profits from Asylum Hotels but Haven't Returned Excess, MPs Told

Epoch Times15-05-2025

Asylum housing providers have made higher profits from hotel use than other accommodation types, but have yet to return excess earnings to the taxpayer, MPs have heard.
Executives from Clearsprings Ready Homes, Serco, and Mears Group appeared before the
The Home Office is responsible for
Private companies such as Clearsprings Ready Homes, Serco, and Mears Group deliver these housing services.
The UK's asylum system uses two types of housing: dispersed accommodation (DA), which is longer-term housing like shared flats managed by contractors, and contingency accommodation, such as hotels or temporary sites used when standard housing runs short.
The financial burden of these arrangements has grown significantly.
Related Stories
7/23/2024
9/6/2024
The total cost of the UK's asylum housing contracts is expected to
Hotel Dependency Under Fire
The committee focused heavily on the continued use of hotels, which now account for 76 percent of annual spending on asylum accommodation, despite housing just 35 percent of people in the system.
Liberal Democrat MP Paul Kohler noted that when the migrant accommodation contracts were determined, the assumption would be most of it being dispersed accommodation.
'Vast amounts are now going to far more expensive contingent hotels, the costs are higher. Therefore 7 percent of that higher turnover is a huge bonus to you, isn't it, in comparison to what was assumed to be the case when the contracts were first established?' he said.
Steve Lakey, managing director of Clearsprings, admitted that hotels are more profitable than other accommodation types, but insisted they were only ever intended as a temporary solution.
'There is a big push and lots of work to try and reduce the hotels and increase the dispersal accommodation,' he told the committee.
This follows the Home Office's pledge
Claudia Sturt of Serco and Jason Burt of Mears echoed the view that hotels were introduced under emergency conditions during the COVID-19 pandemic and should be phased out. Still, they admitted they remain a key part of the system today owing to ongoing pressures and lack of other available accommodation.
The sign outside the Home Office in Westminster, London, on April 29, 2018.
Yui Mok/PA Wire
Providers Acknowledge Profit Margins
Under the UK's asylum accommodation contracts, providers like Clearsprings, Mears, and Serco have a profit-sharing threshold. If their profits exceed the 5percent cap, the excess must be returned to the Home Office.
Clearsprings confirmed that its profit margin had reached 6.9 percent and said £32 million was set aside to be returned, pending audit.
Mears said it expects to return £13.8 million, also awaiting final clearance, while Serco said it has not yet triggered profit-sharing under its contract.
Despite these acknowledgements, MPs criticised the lack of actual payments made to date.
'You haven't paid a pound back into the Home Office,' said Labour MP Shaun Davies.
The providers pointed out that the mechanism for paying back is driven by the Home Office, which is still auditing their accounts.
Committee members also questioned Clearsprings about the personal wealth of its founder, Graham King, who appeared on the Sunday Times Rich List after a 35 percent rise in his net worth.
Lakey declined to comment but emphasised the company's intention to reinvest funds.
Regional Disparities
MPs also questioned the uneven geographic spread of asylum housing, particularly the concentration in London and the southeast.
Lakey explained that the majority of arrivals come into the southeast, mainly through Kent and Croydon intake units, and around airports where they have the most hotel availability.
Providers said they must follow Home Office dispersal plans, which limit how many asylum seekers can be housed per capita in each area.
They praised European models in countries like Switzerland, Germany, and Austria, where local authorities handle housing and integration, suggesting that such devolved systems are more responsive and effective.
According to the latest figures, the number of people accommodated under asylum housing schemes has more than doubled, from around 47,000 in December 2019 to approximately 110,000 in December 2024.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Cuomo flip-flops on flip-flop, supports NYC congestion pricing — after telling The Post he wanted it paused
Cuomo flip-flops on flip-flop, supports NYC congestion pricing — after telling The Post he wanted it paused

New York Post

time39 minutes ago

  • New York Post

Cuomo flip-flops on flip-flop, supports NYC congestion pricing — after telling The Post he wanted it paused

Mayoral hopeful Andrew Cuomo brazenly flipped his flip-flop on congestion pricing – after last year penning a Post op-ed walking back his past support for the scheme. When Cuomo was asked by The New York Times in an interview Tuesday whether he supports congestion pricing now that it shows signs of success, the former governor gave a blunt response: 'Yes.' The supportive stance contrasted with Cuomo's op-ed urging leaders pump the brakes on the controversial plan – which he championed and approved as governor. He had said at the time that imposing the toll on vehicles entering Manhattan south of 60th Street would drive people into an increasingly violent subway system. 3 The op-ed suggested an analysis on the effect of a $15 toll on the city's post-pandemic recovery. 'The people of New York know this is not the time to implement congestion pricing, but where are their local leaders passing resolutions condemning the policy?' he said then. But felony assaults in the subways are 19% percent higher so far this year compared to the same point in 2024, months after Cuomo penned his opinion piece, NYPD data shows. Overall crime in the transit system is down 4.5% over the same span, according to the data. Cuomo insisted during the Times interview that his opinion on congestion pricing has never wavered. 'All I said was, let's study this before we do it in this moment, to make sure people aren't going to say, 'you know what, another reason for me to stay home,'' he said. But Cuomo's apparent flip-flop-flip quickly drew outrage from Cuomo's opponents, political insiders and even supporters of congestion pricing. 3 'He'll say anything and everything to get elected,' Mayor Eric Adams said of Cuomo's congestion pricing about-face. 'He really believes that people don't know his history.' Cuomo had muscled congestion pricing through the state Legislature in 2019, arguing at the time that only 'very rich people' can afford the 'luxury' to drive into Manhattan. After Cuomo resigned as governor in 2021 amid a sexual harassment scandal, he returned from the political wilderness in part by calling to pause congestion pricing. He argued that New Yorkers financially hit by the COVID-19 pandemic couldn't be expected to pay another charge, as well as be shunted into dangerous subways. Curtis Sliwa, the presumptive Republican nominee for mayor, however, saw Cuomo's latest about-face on congestion pricing as yet another craven political calculation. 'Andrew Cuomo isn't interested in governing, he's already scheming for the national stage,' he said. 'He's the king of flip flops, who stands for nothing, puts himself above everyone, and says whatever he thinks will help him get ahead.' Democratic operative Ken Frydman said Cuomo won't be the last politician to change his tune on congestion pricing. 'But now that he's running for mayor of New York City instead of governor of New York State, he's clearly appealing for votes from motorists in the five boroughs,' he said. Another Democratic operative was less charitable. 3 'Andrew Cuomo has no core principles, he'll say whatever it takes to claw his way back into power,' the operative said. 'He's exactly why so many people have lost faith in politics: a flip-flopping wannabe king who ran to the Hamptons when things got tough.' Danny Pearlstein, a spokesman for the pro-congestion pricing NYC Riders Alliance, argued Cuomo has a poor record as governor for mass transit. 'We need a mayor we can trust, not one who lies and falsifies history when it's convenient for him,' Pearlstein said. Cuomo told reporters just after he kicked off his campaign in March that 'preliminary data' pointed to the early success of congestion pricing goals, but added he didn't believe 'all data was in yet.' His campaign officials maintained the ex-gov's stance hasn't changed. 'Governor Cuomo passed congestion pricing in 2019 and nearly two years ago – after being held up for years in Washington – asked the reasonable question about whether we were in the right place economically in our post-pandemic recovery and whether or not drivers had enough confidence in the subways to ditch their cars, or were they just going to work remotely,' his spokeswoman Esther Jensen said. 'These were logical questions that many people were asking. As the governor said yesterday – the indicators are that the program is working.'

‘Phasmophobia' Film in the Works: Blumhouse Developing Adaptation of Horror Video Game
‘Phasmophobia' Film in the Works: Blumhouse Developing Adaptation of Horror Video Game

Yahoo

timean hour ago

  • Yahoo

‘Phasmophobia' Film in the Works: Blumhouse Developing Adaptation of Horror Video Game

Blumhouse Productions has set its sights on another horror video game to adapt to film, developing a feature based on 'Phasmophobia,' the first-person paranormal puzzle title that became a viral sensation during the COVID pandemic. The film adaptation will be produced by Blumhouse and Atomic Monster, in association with Kinetic Games Limited. No distributor or release date has been set. More from Variety 'M3GAN 2.0' Trailer: M3GAN Gets an Upgrade and Faces Another Killer Robot in Horror Sequel 'M3GAN 2.0' Teaser Has the Killer Doll Dancing to Chappell Roan's 'Femininomenon' and Proclaiming: 'The B-- Is Back' Box Office: 'Speak No Evil' Pipes in With $4.9 Million Opening Day, 'Beetlejuice 2' Still Shaking on Top First released in early access in 2020, 'Phasmophobia' became a social media fixation as Twitch streamers and YouTubers quickly took to the multiplayer ghost-hunting video game. Developed and released by Kinetic Games Limited, the title was a breakthrough hit for the indie banner, becoming the best-selling video game on Steam for several weeks through the final months of that year. It has been ported to several consoles and has sold more than 23 million copies globally in the time since. 'Phasmophobia' was also a critical darling, taking the prize in the category of best debut game at the 2020 Game Awards. The project was unveiled at the first-ever 'Business of Fear' event in Hollywood on Tuesday, which featured Blumhouse CEO Jason Blum and president Abhijay Prakash as speakers. It comes as Blumhouse's latest video game adaptation, following their 2023 title 'Five Nights at Freddy's' — another film based on a streamer-popularized horror game. That Universal release grossed $291 million worldwide — an especially impressive figure, considering it had a simultaneous streaming debut on Peacock in North America. A sequel, 'Five Nights at Freddy's 2,' will be released to theaters on Dec. 5. Blumhouse also sports a game division, with upcoming titles including 'Eyes of Hellfire' and 'Sleep Awake.' Best of Variety What's Coming to Netflix in June 2025 New Movies Out Now in Theaters: What to See This Week 'Harry Potter' TV Show Cast Guide: Who's Who in Hogwarts?

Why BioNTech Stock Soared Today
Why BioNTech Stock Soared Today

Yahoo

timean hour ago

  • Yahoo

Why BioNTech Stock Soared Today

BioNTech and Bristol Myers Squibb are teaming up to develop a new cancer drug, BNT327. BioNTech has moved the drug into phase 3 trials, and now Bristol will help to fund further trials. Cash payments to BioNTech could exceed $11 billion over time. 10 stocks we like better than BioNTech Se › BioNTech (NASDAQ: BNTX), one of the companies made famous for its role developing vaccines with Pfizer (NYSE: PFE) during the COVID-19 pandemic, soared 20.2% through 12:50 p.m. Monday on news entirely unrelated to COVID. The German biotech announced this morning it is partnering with pharmaceuticals giant Bristol Myers Squibb (NYSE: BMY) to "co-develop and co-commercialize" BioNTech's drug candidate BNT327 as an immunotherapy against multiple kinds of cancer. BioNTech and Bristol will evenly split the costs of developing and commercializing BNT327, and will "work jointly to broaden and accelerate the development of this clinical candidate." The drug is already involved in "multiple" ongoing clinical trials, including an advanced phase 3 trial testing its usefulness in treating breast cancer and both small cell and non-small cell lung cancer. BioNTech CEO Dr. Uğur Şahin expressed the belief that "BNT327 has the potential to become a foundational immuno-oncology backbone, moving beyond single-mechanism checkpoint inhibitors and expanding into multiple solid-tumor indications." Bristol CEO Christopher Boerner agreed that BNT327 has "significant potential for transforming the standard of care for patients with solid tumors." There are more immediate benefits for BioNTech stock, beginning with Bristol Myers Squibb paying BioNTech $1.5 billion up front for the rights to team up and a further $2 billion in noncontingent payments through 2028 as drug development continues. Additional developmental, regulatory, and commercial milestones, which are contingent on successful development, could add a further $7.6 billion to BioNTech's balance sheet over time. With its lucrative COVID days behind it, BioNTech reported nearly $690 million in losses last year and turned free-cash-flow negative. A tidal wave of cash from Bristol Myers Squibb could really come in handy right about now. Before you buy stock in BioNTech Se, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and BioNTech Se wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $651,049!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $828,224!* Now, it's worth noting Stock Advisor's total average return is 979% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Rich Smith has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Bristol Myers Squibb and Pfizer. The Motley Fool recommends BioNTech Se. The Motley Fool has a disclosure policy. Why BioNTech Stock Soared Today was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store